← Browse by Condition
Medical Condition
merkel cell carcinoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for merkel cell carcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — merkel cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for merkel cell carcinoma?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for merkel cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for merkel cell carcinoma?
merkel cell carcinoma research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a merkel cell carcinoma clinical trial?
Eligibility criteria for merkel cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05078047 Phase 3
Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Enrollment
646 pts
Location
France
Sponsor
UNICANCER
NCT05859074 Phase 1
Recruiting
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Enrollment
56 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT02479698 Phase 2
Recruiting
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Enrollment
100 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06536257
Recruiting
Personalised Immunotherapy Platform
Enrollment
1,000 pts
Location
Australia
Sponsor
Melanoma Institute Australia
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology